This company is a leading developer and manufacturer of generic pharmaceuticals with a focus on providing high-quality products at competitive prices. They operate a large, FDA-approved manufacturing facility equipped with state-of-the-art technology and have the capacity to produce a wide range of dosage forms including tablets, capsules, and powders. Their therapeutic areas include a diverse portfolio spanning multiple categories. The company is known for its expertise in contract manufacturing services, serving as the largest provider for a major pharmaceutical company in the United States. They hold GMP certifications and have secured patents on some of their products. Their reach extends to regions like North America and the EU.

Established in 1972, this Manufacturer is a trusted CTD dossier owner and manufacturer based in Taichung City, Taiwan, with over 50 years of experience. As a GMP manufacturer, it operates state-of-the-art production facilities fully compliant with strict Good Manufacturing Practices (GMP) standards. The Manufacturer offers a diverse product portfolio, including prescription medicines, over-the-counter drugs, and health supplements, focusing on therapeutic areas such as cardiovascular, gastrointestinal, and metabolic health. As a CTD dossier owner and manufacturer, it ensures full compliance with international regulatory requirements. Dedicated to excellence, this GMP manufacturer continues to expand its presence in regulated markets worldwide.

​Established in 1961, this Manufacturer is a CTD dossier owner and manufacturer based in Taichung City, Taiwan. It operates GMP-certified facilities producing a diverse range of products, including tablets, capsules, oral liquids, external liquids, and health foods. As a GMP manufacturer, it ensures adherence to international quality standards. The Manufacturer's products are distributed across various countries and regions worldwide. Its commitment to excellence as a CTD dossier owner and manufacturer and GMP manufacturer solidifies its reputation in the global pharmaceutical market.​